课题基金 / 基金详情

Analysis of survival signaling and its application for a new therapeutic strategy of cancers in gastro-intestinal tract and liver.

Analysis of survival signaling and its application for a new therapeutic strategy of cancers in gastro-intestinal tract and liver.
生存信号分析及其在胃肠道和肝癌新治疗策略中的应用。
批准号:
14370182
负责人:
SASAKI Yutaka
金额:
$8.45万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

SASAKI Yutaka的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Different from another form of cell death called necrosis, a morphological-defined cell death, called apoptosis, has been recently observed. Apoptosis is initiated by death ligands, or by a variety of stimuli including chemotherapy, and y-irradiation.Apoptosis is strictly controlled by a variety of mechanisms at different levels. Inside the cells, the members of Bcl-2 family constitute a first class of regulatory proteins, which act at the mitochondrial level. BAD, a member of Bcl-2 family exerts its pro-apoptotic action on the mitochondrion in the non-phosphorylated state, and forms inactivating dimmers with Bel-XL or Bcl-2 to promote apoptosis. Phosphorylated BAD dissociates from the heterodimeric complex with Bel-XL or Bcl-2,restoring Bel-XL or Bcl-2 function, and activating cell survival signaling. Recent works have indicated that activated BAD kinases including Akt or PKA (A kinase) in the tumor cells play a key role in apoptosis resistance through BAD phosphorylation. We investig … More ated the involvement of intracellular survival signals in human hepatocellular carcinoma(HCC). Both Akt and PKA. were activated in HCCs compared to adjacent non-involved tissues. BAD protein was highly phosphorylated in HCCs compared to uninvolved liver. There was significant correlation between Akt or PKA activity and BAD phosphorylation in HCCs. In addition, inhibitors of these signal transduction cascade induced programmed cell death in human hepatoma cell lines. These observations indicate that survival signal suppresses programmed cell death via BAD phosphorylation in human HCCs, and suggest that it may promote escape from apoptosis to allow HCC tumor progression.On the other hand, mitogen-activated protein kinase(MAPK) cascade is activated in response to various extracellular stimuli. We examined involvement of p38 MAPK, a MAPK super family, cascade in human HCCs and hepatoma cell lines. In HCCs,MKK6,which is upstream of p38 MAPK, and p38 MAPK activities were significantly lower compared to non-tumorous lesions. There was a significant positive correlation between p38 MAPK and MKK6 activity. Moreover, there was a positive correlation between p38 MAPK and caspase-3 activity. HCCs measuring over 20 mm exhibited lower levels of MKK6 and p38 MAPK activity than did smaller tumors. MKK6 transfection increased p38 MAPK activity, cytochrome c release from the mitochondria to the cytosol, and caspase-3 activity, accompanied by apoptosis in hepatoma cell lines. In contrast, a p38 MAPK specific inhibitor prevents MKK6-induced apoptosis in hepatoma cell lines. These results indicate that the p38 MAPK cascade is consistent with induction of a programmed cell death pathway in hepatoma cells, and suggest that reduction of the p38 MAPK cascade may account, in part, for escape from apoptosis, leading to the progression of human HCC.Taking together, the modulation of activated survival signals and diminished apoptotic signals may serve as a new therapeutic strategy for cancer therapy. Less
期刊论文(86)
专著(0)
科研奖励(0)
会议论文
Housui, A., et al.: "Hepatitis C virus core protein differently regulates the JAK-STAT signaling pathway under interleukin-6 and interferon -gamma stimuli"J.Biol.Chem.. 278. 28562-28571 (2003)
Housui, A., et al.:“丙型肝炎病毒核心蛋白在白细胞介素 6 和干扰素 -gamma 刺激下不同地调节 JAK-STAT 信号通路”J.Biol.Chem.. 278. 28562-28571 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasumaru, M., et al.: "Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway"Cancer Res.. 63. 6726-6734 (2003)
Yasumaru, M., 等人:“抑制血管紧张素 II 活性可通过胰岛素样生长因子 I 受体途径增强环氧合酶 2 抑制剂的抗肿瘤作用”Cancer Res.. 63. 6726-6734 (2003)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Frontiers in Hepatology, HCV/Oxidative Stress and Liver Disease
肝病学、HCV/氧化应激和肝病前沿
DOI: --
发表时间: 2002
期刊: Hepatitis C virus core-mediated alteration of gene expression and signal transduction in the host cell(ed.K.Okita)(Springer-Verlag, Tokyo)
影响因子: --
作者: [Ohkawa, K., Housui, A., Sasaki, Y., Hayashi, N.]
通讯作者: N.
DOI: 10.1152/ajpgi.00006.2002
发表时间: 2002-12-01
期刊: AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
影响因子: 4.5
作者: [Komori, M, Tsuji, S, Hori, M]
通讯作者: Hori, M
27
    Scholarly Activities of the Social Science Research Council to Construct the Interdisciplinary Knowledge of the Social Sciences
    • 批准号:
      19K01513
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      2019
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    Investigation of c-ktlow murine hematopoietic stem cells for the role in aged animals
    • 批准号:
      25460483
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2013
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    NMR of extremely diluted impurity helium-3in quantum solid helium-4
    • 批准号:
      22654039
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.95万
    • 财政年份:
      2010
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    Analysis of mechanisms underlying treatment-resistance ofhepatocelluar carcinoma in the point view of post-translationalmodification evaluated by proteomics
    • 批准号:
      21390230
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      SASAKI Yutaka
    • 依托单位:
    国内基金
    海外基金
    Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
    • 批准号:
      LBY21H010001
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2020
    • 负责人:
      郑绪阳
    • 依托单位:
    去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
    • 批准号:
      31970691
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2019
    • 负责人:
      张胜萍
    • 依托单位:
    TM9SF4调控非小细胞肺癌细胞凋亡机制研究
    • 批准号:
      31900527
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2019
    • 负责人:
      孙磊
    • 依托单位:
    基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
    • 批准号:
      81703335
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      20.0万元
    • 批准年份:
      2017
    • 负责人:
      卫高菲
    • 依托单位: